Published ahead of print on October 25, 2007, doi:10.1164/rccm.200612-1890OC
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 208-218, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200612-1890OC
IFN- Production during Initial Infection Determines the Outcome of Reinfection with Respiratory Syncytial Virus
Young-Mok Lee1,
Nobuaki Miyahara1,
Katsuyuki Takeda1,
John Prpich1,
Anita Oh1,
Annette Balhorn1,
Anthony Joetham1,
Erwin W. Gelfand1 and
Azzeddine Dakhama1
1 Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado
Correspondence and requests for reprints should be addressed to Azzeddine Dakhama, Ph.D., Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206. E-mail: dakhamaa{at}njc.org
Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN- production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown.
Objectives: To define the role of IFN- in the development of RSV-mediated airway hyperresponsiveness (AHR) and lung histopathology in mice.
Methods: Wild-type (WT) and IFN- knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection.
Measurements and Main Results: Both WT and IFN- knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN- knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN- during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN- knockout mice. Adoptive transfer of WT T cells into IFN- knockout mice before primary infection restored IFN- production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN- during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection.
Conclusions: IFN- production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN- during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.
Key Words: respiratory syncytial virus interferon- asthma airway hyperresponsiveness mice
| AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Deficient IFN- production has been associated with respiratory syncytial virus (RSV) bronchiolitis. However, the role of IFN- in determining the outcome of reinfection with RSV remains unknown.
What This Study Adds to the Field
IFN- plays a critical role during initial infection that determines the outcome of reinfection with RSV. Provision of IFN- may interfere with the development of altered airway responses to reinfection in children.
|
This article has been cited by other articles:

|
 |

|
 |
 
S. S. Mohapatra and S. Boyapalle
Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma
Clin. Microbiol. Rev.,
July 1, 2008;
21(3):
495 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Tregoning, Y. Yamaguchi, J. Harker, B. Wang, and P. J. M. Openshaw
The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice
J. Virol.,
April 15, 2008;
82(8):
4115 - 4124.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 American Thoracic Society
|
|
|